MC38-hCD39

Export PDF

Strain Information

Cell Line

MC38-hCD39

Cat. NO.

NM-S13-TM83

Model Description

CD47 gene humanized WEHI 169 cell line

Strain State

Validation of pharmacodynamic assays completed

Validation Data

image.png

Figure 1. hCD39 expression in MC38-hCD39 cell line.

image.png

Figure 2. Tumor growth curve of MC38-hCD39 syngeneic model (n=4).

image.png

Figure 3. Body weight change of MC38-hCD39 syngeneic model (n=4).

image.png

Figure 4. The expression of hCD39 in humanized modified tumors by FACS.

image.png

Figure 5. Antitumor activity of three different antibodies (n=6).

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more